Viewing Study NCT01606566

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:27 PM
Ignite Modification Date: 2026-01-03 @ 8:10 AM
Study NCT ID: NCT01606566
Status: TERMINATED
Last Update Posted: 2022-02-18
First Post: 2012-05-21
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Evaluate the Safety and Efficacy of Amphinex Induced PCI of Bleomycin for Recurrent Head and Neck Cancer.
Sponsor: PCI Biotech AS
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Head and Neck Cancer View
None Carcinoma, Squamous Cell of Head and Neck View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Recurrent View
None Head and Neck View
None Neoplasms View
None Squamous Cell Carcinoma View
None Amphinex View
None Cancer View
None Photodynamic therapy View
None Chemotherapy View
None Bleomycin View